The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
MRI has emerged as one of several urgently needed candidate disease progression biomarkers for the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), not least due to its unique ability to non-invasively assess structural and functional cerebral pathology. We sought to identify the exte...
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Journal article |
| Argitaratua: |
Elsevier
2017
|